Filed: 11/10/2025ACC: 0001909617-25-000004
📋 What this filing means
QIMING U.S. VENTURES MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 4 equity positions with a total reported market value of $55.64M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
4
Positions
$55.64M
Total AUM (reported)
2.12M
Total Shares
Allocation by class
COM$53.10M95.4%
COM NEW$2.53M4.6%
Portfolio Concentration
Top 3$55.31M99.4%
4–10$323.2K0.6%
Top 3 weight
99.4%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 2.12M
Sole
Full voting authority
2.12M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole4
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings4
Rows:
TOURMALINE BIO INC
SOLEShares741.69K
TypeSH
Market value$35.48M
63.76%
Sole
741.69K
Shared
0.00
None
0.00
KORRO BIO INC
SOLEShares368.08K
TypeSH
Market value$17.63M
31.68%
Sole
368.08K
Shared
0.00
None
0.00
JASPER THERAPEUTICS INC
SOLEShares928.96K
TypeSH
Market value$2.21M
3.97%
Sole
928.96K
Shared
0.00
None
0.00
KEZAR LIFE SCIENCES INC
SOLEShares82.87K
TypeSH
Market value$323.2K
0.58%
Sole
82.87K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
TOURMALINE BIO INCSOLE | COM | 741.69K | SH | $35.48M 63.76% | 741.69K | 0.00 | 0.00 |
KORRO BIO INCSOLE | COM | 368.08K | SH | $17.63M 31.68% | 368.08K | 0.00 | 0.00 |
JASPER THERAPEUTICS INCSOLE | COM NEW | 928.96K | SH | $2.21M 3.97% | 928.96K | 0.00 | 0.00 |
KEZAR LIFE SCIENCES INCSOLE | COM NEW | 82.87K | SH | $323.2K 0.58% | 82.87K | 0.00 | 0.00 |